Dissolved and financials
CVR: 18866692
DKK 0
Gross profit
Net result: DKK -32,586
No owners listed
CVR · view owners
No current management
CVR · view management
Dissolved
Ceased 30 September 2025
CVR · view overview
0 employees
CVR · 2003
Director role ended: Esben Joakim de Meza Skjernov
CVR · 01/05/2025
View the full event history
NORDIA PHARMACEUTICAL COMPANY ApS was a Danish company of the type Anpartsselskab based in Hillerød, founded in 1995. The company has been dissolved on 30 September 2025. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company has 0 employees (2003). In 2024, the company reported a gross profit of DKK 0 and a net result of DKK -32,586 compared with DKK -80,828 the year before. Equity in the 2024 report amounted to DKK -214,980.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202401/01/2024 – 31/12/2024 | 0 | -33K | 13K | -215K | - | |
| 202301/01/2023 – 31/12/2023 | 0 | -81K | 14K | -182K | - | |
| 202201/01/2022 – 31/12/2022 | 0 | -69K | 16K | -102K | - | |
| 202101/01/2021 – 31/12/2021 | 0 | -53K | 17K | -32K | - | |
| 202001/01/2020 – 31/12/2020 | 52K | -24K | 21K | 21K | - | |
| 201901/01/2019 – 31/12/2019 | 164K | 73K | 62K | 45K | - | |
| 201801/01/2018 – 31/12/2018 | 96K | 4K | 56K | -28K | - | |
| 201701/01/2017 – 31/12/2017 | 25K | -44K | 13K | -32K | - | |
| 201601/01/2016 – 31/12/2016 | 51K | -98K | 97K | 12K | - | |
| 201501/01/2015 – 31/12/2015 | 72K | 27K | 130K | 110K | - | |
| 201401/01/2014 – 31/12/2014 | 0 | -22K | 128K | 83K | - | |
| 201301/01/2013 – 31/12/2013 | 0 | -71K | 125K | 105K | - | |
| 201201/01/2012 – 31/12/2012 | 38K | -176K | 193K | 175K | - |
Compared to 127 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreNo. NORDIA PHARMACEUTICAL COMPANY ApS is registered in the Danish CVR register with the status Dissolved and ceased on 30 September 2025.
The CVR number of NORDIA PHARMACEUTICAL COMPANY ApS is 18866692.
In 2024, NORDIA PHARMACEUTICAL COMPANY ApS reported a gross profit of DKK 0.
NORDIA PHARMACEUTICAL COMPANY ApS had 0 employees in 2003 according to the Danish CVR register.
NORDIA PHARMACEUTICAL COMPANY ApS was founded on 31 August 1995.
NORDIA PHARMACEUTICAL COMPANY ApS was registered under the industry Fremstilling af farmaceutiske præparater (industry code 212000).
NORDIA PHARMACEUTICAL COMPANY ApS was dissolved on September 30, 2025.
As of May 1, 2025, Esben Joakim de Meza Skjernov has stepped down as liquidator of NORDIA PHARMACEUTICAL COMPANY ApS.
On May 1, 2025, NORDIA PHARMACEUTICAL COMPANY ApS exited liquidation.
As of April 4, 2025, Esben Joakim de Meza Skjernov is registered as liquidator of NORDIA PHARMACEUTICAL COMPANY ApS.
On April 4, 2025, NORDIA PHARMACEUTICAL COMPANY ApS entered liquidation.
As of February 24, 2025, EY Godkendt Revisionspartnerselskab has stepped down as auditor of NORDIA PHARMACEUTICAL COMPANY ApS.
As of January 22, 2025, Rune Paulsen Kure has left the board of directors of NORDIA PHARMACEUTICAL COMPANY ApS.
As of January 22, 2025, Mathias Bastrup Kure has left the board of directors of NORDIA PHARMACEUTICAL COMPANY ApS.
As of January 22, 2025, Rune Paulsen Kure has stepped down as adm. dir. of NORDIA PHARMACEUTICAL COMPANY ApS.
As of January 22, 2025, Gabriel Kure has stepped down as chairman of NORDIA PHARMACEUTICAL COMPANY ApS.
NORDIA PHARMACEUTICAL COMPANY ApS has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK -32,586.
NORDIA PHARMACEUTICAL COMPANY ApS has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK -80,828.
NORDIA PHARMACEUTICAL COMPANY ApS has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -69,208.
NORDIA PHARMACEUTICAL COMPANY ApS has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK -52,885.
NORDIA PHARMACEUTICAL COMPANY ApS has published its annual report for 2020. Revenue came to DKK 51,693, and the net result was DKK -24,462.
NORDIA PHARMACEUTICAL COMPANY ApS has published its annual report for 2019. Revenue came to DKK 164,366, and the net result was DKK 73,002.
As of May 28, 2020, Mathias Bastrup Kure has joined the board of directors of NORDIA PHARMACEUTICAL COMPANY ApS.
As of May 28, 2020, Gabriel Kure is registered as chairman of NORDIA PHARMACEUTICAL COMPANY ApS.
As of May 27, 2020, Gabriel Kure has left the board of directors of NORDIA PHARMACEUTICAL COMPANY ApS.
As of May 27, 2020, Mathias Bastrup Kure has stepped down as chairman of NORDIA PHARMACEUTICAL COMPANY ApS.
NORDIA PHARMACEUTICAL COMPANY ApS has published its annual report for 2018. Revenue came to DKK 95,567, and the net result was DKK 4,409.
As of January 31, 2019, Rune Paulsen Kure has joined the board of directors of NORDIA PHARMACEUTICAL COMPANY ApS.
As of January 31, 2019, Gabriel Kure has joined the board of directors of NORDIA PHARMACEUTICAL COMPANY ApS.
As of January 31, 2019, Birgitte Kure has left the board of directors of NORDIA PHARMACEUTICAL COMPANY ApS.
As of January 31, 2019, Rune Paulsen Kure is registered as adm. dir. of NORDIA PHARMACEUTICAL COMPANY ApS.
As of January 31, 2019, Mathias Bastrup Kure is registered as chairman of NORDIA PHARMACEUTICAL COMPANY ApS.
As of January 31, 2019, Birgitte Kure has stepped down as director of NORDIA PHARMACEUTICAL COMPANY ApS.
As of January 30, 2019, Rune Paulsen Kure has stepped down as chairman of NORDIA PHARMACEUTICAL COMPANY ApS.
NORDIA PHARMACEUTICAL COMPANY ApS has published its annual report for 2017. Revenue came to DKK 24,512, and the net result was DKK -43,942.
NORDIA PHARMACEUTICAL COMPANY ApS has published its annual report for 2016. Revenue came to DKK 50,907, and the net result was DKK -98,091.
NORDIA PHARMACEUTICAL COMPANY ApS has published its annual report for 2015. Revenue came to DKK 72,493, and the net result was DKK 26,920.
NORDIA PHARMACEUTICAL COMPANY ApS has published its annual report for 2014. Revenue came to DKK 0, and the net result was DKK -22,158.
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of NORDIA PHARMACEUTICAL COMPANY ApS.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of NORDIA PHARMACEUTICAL COMPANY ApS.
NORDIA PHARMACEUTICAL COMPANY ApS has published its annual report for 2013. Revenue came to DKK 0, and the net result was DKK -70,584.
NORDIA PHARMACEUTICAL COMPANY ApS has published its annual report for 2012. Revenue came to DKK 37,674, and the net result was DKK -176,420.
As of May 30, 2012, Bertel Willy Rønne has left the board of directors of NORDIA PHARMACEUTICAL COMPANY ApS.
As of August 18, 2011, JUT NR. 2180 A/S has been appointed auditor of NORDIA PHARMACEUTICAL COMPANY ApS.
As of August 18, 2011, EY Danmark A/S has stepped down as auditor of NORDIA PHARMACEUTICAL COMPANY ApS.
As of May 30, 2000, Bertel Willy Rønne has joined the board of directors of NORDIA PHARMACEUTICAL COMPANY ApS.
As of August 31, 1995, EY Danmark A/S has been appointed auditor of NORDIA PHARMACEUTICAL COMPANY ApS.
As of August 31, 1995, Birgitte Kure has joined the board of directors of NORDIA PHARMACEUTICAL COMPANY ApS.
As of August 31, 1995, Rune Paulsen Kure is registered as chairman of NORDIA PHARMACEUTICAL COMPANY ApS.
As of August 31, 1995, Birgitte Kure is registered as director of NORDIA PHARMACEUTICAL COMPANY ApS.
NORDIA PHARMACEUTICAL COMPANY ApS was founded on August 31, 1995.
Companies in the same industry and area
CVR 37724688
CVR 46705289
CVR 37294535
CVR 89669510
CVR 26060702
